Show item record

dc.contributor.authorBolanis, Despina
dc.contributor.authorOrri, Massimiliano
dc.contributor.authorCastellanos Ryan, Natalie
dc.contributor.authorRenaud, Johanne
dc.contributor.authorMontreuil, Tina
dc.contributor.authorBoivin, Michel
dc.contributor.authorVitaro, Frank
dc.contributor.authorTremblay, Richard Ernest
dc.contributor.authorTurecki, Gustavo
dc.contributor.authorCôté, Sylvana
dc.contributor.authorSéguin, Jean
dc.contributor.authorGeoffroy, Marie-Claude
dc.date.accessioned2021-04-22T17:25:21Z
dc.date.availableMONTHS_WITHHELD:12fr
dc.date.available2021-04-22T17:25:21Z
dc.date.issued2020-05-29
dc.identifier.urihttp://hdl.handle.net/1866/24963
dc.publisherElsevierfr
dc.rightsCe document est mis à disposition selon les termes de la Licence Creative Commons Attribution - Pas d’utilisation commerciale - Pas de Modification 4.0 International. / This work is licensed under a Creative Commons Attribution - NonCommercial - No modification 4.0 International License.
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.fr
dc.subjectLongitudinalfr
dc.subjectAdolescencefr
dc.subjectCannabisfr
dc.subjectDepressionfr
dc.subjectSuicidal ideationfr
dc.subjectSubstance usefr
dc.titleCannabis use, depression and suicidal ideation in adolescence : direction of associations in a population based cohortfr
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. École de santé publique. Département de médecine sociale et préventivefr
dc.identifier.doi10.1016/j.jad.2020.05.136
dcterms.abstractBackground To clarify the direction of the association between frequency of cannabis use, depressive symptoms and suicidal ideation from 15 to 20 years using cross-lagged analyses. Method We included 1606 adolescents from the province of Québec followed since 1997 with information on frequency of cannabis use (none/monthly/weekly), depression (defined as being in the top 10% symptoms) and serious suicidal ideation at ages 15, 17 and 20 years. Results The prevalence of weekly cannabis use increased from 7.0% at age 15 years to 15.6% by age 20 years. Adolescents who reported using cannabis weekly at one age were 11 to 15 times more likely to continue using cannabis over time. In longitudinal cross-lagged analyses, weekly cannabis use at age 15 was associated with greater odds (OR=2.19, 95% CI=1.04-4.58) of suicidal ideation two years later. However, other substance use (alcohol, tobacco, other drugs) fully explained this association. Further, depression predicted subsequent weekly cannabis use, even after adjusting for comorbid other substance use (eg, for depression at 15 years predicting cannabis use at 17 years: OR=2.30, 95% CI=1.19-4.43). Limitations Quantity of cannabis consumed was not measured. Conclusion Findings suggest that depressive symptoms in adolescence may represent a risk factor for weekly cannabis consumption, which once initiated is likely to remain chronic. Weekly cannabis use increased risk for suicidal ideation, but not independently from other substance use including alcohol, tobacco and other drugs.fr
dcterms.isPartOfurn:ISSN:0165-0327fr
dcterms.languageengfr
UdeM.ReferenceFournieParDeposanthttps://doi.org/10.1016/j.jad.2020.05.136fr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscriptfr
oaire.citationTitleJournal of affective disordersfr
oaire.citationVolume274fr
oaire.citationStartPage1076fr
oaire.citationEndPage1083fr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

Ce document est mis à disposition selon les termes de la Licence Creative Commons 
Attribution - Pas d’utilisation commerciale - Pas de Modification 4.0 International. / This work is licensed under a 
Creative Commons Attribution - NonCommercial - No modification  4.0 International License.
Usage rights : Ce document est mis à disposition selon les termes de la Licence Creative Commons Attribution - Pas d’utilisation commerciale - Pas de Modification 4.0 International. / This work is licensed under a Creative Commons Attribution - NonCommercial - No modification 4.0 International License.